Over the last decade, scientists have had a renewed interest in vaccines due to improved technology and biological discovery.
A new vaccine design uses folded DNA to steer the immune system toward producing the rare immune cells needed to make protective antibodies against HIV.
Ethris GmbH, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics and vaccines, and the German Center for Infection Research (Deutsches Zentrum für Infektionsforschung, ...
With a budget of up to $20m, the collaboration will establish scalable, rapid manufacturing for recombinant-protein vaccines.
A new study has shown for the first time that an experimental vaccine against Middle East Respiratory Syndrome (MERS) induces ...
Recent reports of Nipah virus (NiV) infections in West Bengal, India, have reignited global concern, prompting public health ...
Oral vaccines promise painless, needle-free protection—but the human gut evolved to destroy exactly what vaccines are made of ...